[1]
Achdiat, P.A., Widjaja, S., Suwarsa, O., Dwiyana, R.F., Hindritiani, R., Sutedja, E., Gunawan, H., Usman, H.A., Rianty, F. and Maharani, R.H. 2024. Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus. Dermatology Reports. (Jan. 2024). DOI:https://doi.org/10.4081/dr.2024.9754.